No Data
No Data
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
TD Cowen Maintains Protara Therapeutics(TARA.US) With Buy Rating
We Think Protara Therapeutics (NASDAQ:TARA) Needs To Drive Business Growth Carefully
H.C. Wainwright Maintains Protara Therapeutics(TARA.US) With Buy Rating, Maintains Target Price $23
Promising Efficacy of TARA-002 Positions Protara Therapeutics as a Compelling Buy for HR-NMIBC Treatment
Express News | HC Wainwright & Co. Reiterates Buy on Protara Therapeutics, Maintains $23 Price Target
No Data